来源: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol, Apr 01, ...
2.A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction.JACC Heart Fail.2022;10(2):73-84. doi: 10.1016/j.jchf.2021.09.004. 3.CCS/CHFS Heart Failure Guidelines Update:...
[10]. Heidenreich PA, Bozkurt B, Aguilar D, etal. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. Circulation, 2022, 145(18):e895-1032. [11]. Brou...
Study Type :Interventional (Clinical Trial)Estimated Enrollment :63 participantsAllocation:RandomizedIntervention Model:Parallel AssignmentIntervention Model Description:Double-blind, placebo-controlled, single-ascending dose with single active sentinel subject per cohortMasking:Quadruple (Participant, Care Provider...
[4] M Ferrari et al. Real world data comparing HF guideline directed medical therapy before and after 2021 ESC HF guidelines. 2023 ESC-HFA. [5] C Paitazoglou, et al. Safety and efficacy of induced pluripotent stem cell-derived engineered human myocardium as biological ventricular assist tissu...
disparities exist in the exclusion of patients from the prescription of GDMT.#Methods:Data were collected retrospectively through the Get With The Guidelines- Heart Failure registry for HFrEF (LVEF =<40%) patients admitted at NYC Health+Hospital/Jacobi Medical Center from 1/1/2017-5/31/2022. On...
However, 91% of participants in China were finishing their follow-up in late 2022, when the country was hit by a COVID-19 surge, which might have affected the 12-week outcomes — though this is speculation for now. Overall, participants had a mean age of 57 years; about 80% were men...
In GALACTIC-HF, 8,256 HFrEF patients with LVEF 35% or less were randomized to omecamtiv mecarbil or placebo. The primary composite outcome of hospitalization or urgent visit for heart failure or death from cardiovascular causes was evaluated after a median of 21.8 months on therapy. ...
Abstract The role of metformin (MET) in the treatment of patients with advanced HFrEF and type 2 diabetes mellitus (DM) is not firmly established. We studied the impact of MET on metabolic profile, quality of life (QoL) and survival in these patients. A total of 847 stable patients with ...
The trial is conducted in keeping with Good Clinical Practice Guidelines, the principles outlined in the Declaration of Helsinki, and applicable local laws and regulations. The trial is registered at www.chictr.org.cn under the identification number ChiCTR2100049834. Consent for publication Not ...